1. Home
  2. Analysis
  3. Humalog
  4. Pepcid-complete

Humalog and Pepcid complete drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Pepcid complete (calcium carbonate; famotidine; magnesium hydroxide). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Pepcid complete. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Pepcid complete?

Pepcid complete has active ingredients of calcium carbonate; famotidine; magnesium hydroxide. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 2,884 Pepcid complete users. Check the latest studies of Pepcid complete.

On Jul, 26, 2026

18 people who take Humalog and Pepcid complete together, and have interactions are studied.

Humalog and Pepcid complete drug interactions.

What are the common drug interactions of Humalog and Pepcid Complete, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Communication disorder (speech and language disorder)
  4. Death
  5. Dementia (madness)
  6. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Humalog and Pepcid Complete, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 12 people, 66.67%
  2. High Blood Pressure: 11 people, 61.11%
  3. Infection: 9 people, 50.00%
  4. High Blood Cholesterol: 9 people, 50.00%
  5. Indigestion: 5 people, 27.78%
  6. Swelling: 4 people, 22.22%
  7. Depression: 4 people, 22.22%
  8. Stress And Anxiety: 3 people, 16.67%
  9. Blood Pressure Abnormal: 3 people, 16.67%
  10. Chest Pain: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Pepcid complete?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humalog and Pepcid complete:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pepcid complete:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid complete and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant and calcium carbonate; famotidine; magnesium hydroxide (the active ingredients of Humalog and Pepcid complete, respectively), and Humalog and Pepcid complete (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.